Diego Kyburz

Prof. Dr. med. 
Diego Kyburz

Position(s)
Head of Department Rheumatology

Institution
University Hospital Basel

Phone +41 61 328 74 81

Email

 

Research Focus

Immunology & Infectious Diseases

Area of Research

Experimental Rheumatology


Approved Research Projects

Exploring Novel Mechanisms In Autoimmune And Inflammatory Diseases-BASICHR0003
Novartis Pharma Schweiz AG, 11.2020-10.2022 (24)
PI : Kyburz, Diego DKF

A Randomized Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients
with Rheumatoid Arthritis
Eli Lilly,  07.2019-06.2022 (36)
CI : Kyburz, Diego DKF

A Phase 3, Randomized, Active-Controlled, Double-Blind Study Comparing ABT-494 to
Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with
Inadequate Response or Intolerance to Biologic DMARDs (bDMARDs) on Stable Conventional
Synthetic Disease Modifying Anti-Rheumatic Drugs (csDMARDs)
Abbvie AG,  05.2018-04.2021 (36)
PI : Kyburz, Diego DKF

Identification of biomarkers and therapeutic targets in inflammatory disease immunotherapy by
high-dimensional single cell analysis and cluster proteomics
Swiss Personalized Health Network (SAMW), 02.2018-01.2021 (36)
CI : Kyburz, Diego DKF

EXPLORING NOVEL MECHANISMS IN AUTOIMMUNE AND INFLAMMATORY DISEASES
Novartis Pharma, 11.2018-10.2020 (24)
PI : Kyburz, Diego DKF

EXPLORING NOVEL MECHANISMS IN AUTOIMMUNE AND INFLAMMATORY DISEASES
Novartis Pharma, 12.2016-11.2018 (24)
PI : Kyburz, Diego DKF

Patients with autoimmune diseases
Hoffmann-La Roche, 09.2016-08.2018 (24)
PI : Kyburz, Diego DKF

Prospective observational study entitled “TofaSwiss Study - A Real Life Experience with
tofacitinib. Data from the Swiss SCQM registry
SCQM Foundation, 09.2015-08.2017 (24)
PI : Kyburz, Diego DKF

Randomized double blind Placebo controlled Phase III multicenter study of sc secukinumab in
patients with active ankylosing spondylitis
Novartis Pharma, 11.2013-07.2017 (45)
PI : Kyburz, Diego DKF

ASCORE Studie: Langzeiterfahrungen mit Abatacept sc in der täglichen Praxis
BMS (Bristol-Myers Squibb), 11.2013-04.2017 (42)
PI : Kyburz, Diego DKF

A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo on Stable
Conventional Synthetic Disease-Modifying Anti Rheumatic Drugs (csDMARDs) in Subjects
with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or
Intolerance to Biologic DMARDs (bDMARDs)
Abbvie AG, 03.2016-02.2017 (12)
PI : Kyburz, Diego DKF


Collaborations

National Collaborations
Swiss Clinical Quality Management in Rheumatic Diseases (SCQM): national registry for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, giant cell arteritis, polymyalgia rheumatica. Established collaboration with the Swiss university centers and contributing hospitals.

International Collaborations
EUSTAR: European registry for systemic sclerosis


Ongoing Research Projects

SCQM studies

  • Comparative effectiveness of JAK inhibitor versus TNF inhibitor therapy in patients with RA who have discontinued a previous JAK inhibitor, PI Diego Kyburz
  • Predictors for loss of productivity and the effect of b/tsDMARD treatment on loss of productivity in Swiss patients with rheumatoid arthritis, PI Diego Kyburz

Translational studies

  • Identification of biomarkers prediction transition from psoriasis to psoriatic arthritis.Research collaboration with industry (agreement pending), PI Diego Kyburz / Tobias Manigold
  • Extracellular vesicle analysis in synovial fluid from patients with RA and osteoarthritis (OA), PI Diego Kyburz
  • The role of urate and calcium pyrophosphate crystals in the activation of macrophages in gout and pseudogout, PI Diego Kyburz

Multicenter clinical trials

  • Participation in various phase II, III and IV studies in RA, spondyloarthritis, systemic lupus erythematosus, giant cell arteritis. Local PI Diego Kyburz, Thomas Daikeler, Ulrich Walker.

Research Team

Bettina Bannert

Study doctor/Co-PI

Phone +41 61 556 50 17
Email

Anja Halbartschlager

Study nurse

Phone -
Email -

Lena Bigliel

Study nurse

Phone +41 61 328 50 84
Email

Aurora Frei

Study nurse

Phone +41 61 556 51 36
Email